The Lupus Research Alliance invites applications for its lupus mechanisms and targets award. This supports research focused on the identification and investigation of molecular pathways or targets that will lead to new or improved therapies for patients with lupus.
The goals of this award are to:
•characterise key steps in the pathogenesis of the disease that will allow for the development of new therapeutic agents;
•promote basic and clinical research studies to identify or better characterise promising lead compounds for lupus treatment;
•support research that facilitates the clinical evaluation of innovative approaches to the prevention, management or treatment of lupus and its complications.
Research that applies knowledge gained in other disease areas, such as other autoimmune and inflammatory conditions, cancer or metabolic diseases, to mechanisms relevant to lupus are encouraged.
Individuals with a doctoral degree such as an MD, PhD or DO, holding a faculty, or equivalent, position at an academic, non-profit or government research institution are eligible to apply. There are no citizenship requirements. Research in industry or collaborations between academia and industry are supported.
Grants are worth up to USD 200,000 per year for up to three years.
Deadline: 15th January 2022.